1. Home
  2. TG vs INBX Comparison

TG vs INBX Comparison

Compare TG & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.20

Market Cap

273.5M

Sector

Industrials

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$67.92

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
INBX
Founded
1988
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.5M
999.7M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
TG
INBX
Price
$8.20
$67.92
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
114.1K
156.8K
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
N/A
EPS
0.96
N/A
Revenue
$800,821,000.00
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.28
N/A
Revenue Growth
8.29
550.00
52 Week Low
$6.25
$10.81
52 Week High
$9.66
$94.57

Technical Indicators

Market Signals
Indicator
TG
INBX
Relative Strength Index (RSI) 51.95 48.77
Support Level $7.52 $28.54
Resistance Level $9.26 $85.97
Average True Range (ATR) 0.30 4.60
MACD 0.04 0.29
Stochastic Oscillator 87.31 68.96

Price Performance

Historical Comparison
TG
INBX

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: